Apremilast Is Efficacious in Refractory Alopecia Areata
May 2019
in “
Journal of dermatological treatment
”
New to Alopecia Areata? There is a guide in the encyclopedia. Read the guide → 
Studysummary This article reviews characteristics and mental health impacts of alopecia areata but provides no new clinical findings; future research is encouraged.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
The study concluded that Apremilast, an oral phosphodiesterase 4 inhibitor, was effective in treating refractory alopecia areata (AA). The research involved a small cohort of patients who had not responded to conventional therapies. The results showed significant hair regrowth in these patients, suggesting that Apremilast could be a promising treatment option for those with difficult-to-treat AA. The findings provided hope for improved management of this challenging autoimmune condition.
